Terconazole Cream
Product Images NDC 51672-1302

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terconazole (NDC 51672-1302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Terconazole 01)

FDA Label Image

Figure 1 (Terconazole 02)

FDA Label Image

Figure 2 (Terconazole 03)

FDA Label Image

Figure 3 (Terconazole 04)

FDA Label Image

Figure 4 (Terconazole 05)

Figure 4 (Terconazole 05)
This appears to be a list of anatomical structures in the pelvic region of the body: the urinary opening, the vagina, and the rectum.*
FDA Label Image

Principal Display Panel (20 g Tube Carton)

Principal Display Panel (20 g Tube Carton)
This is a leaflet containing important patent information for a vaginal cream with terconazole 0.8%. It includes instructions for use, storage information, medication precautions, and a warning to keep it out of reach of children. The leaflet also mentions a combined insert for pharmacists and instructions for dispensing prescription medication. Additionally, there are some unreadable characters and a code at the end.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.